Caris Life Sciences®(Caris), the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare, announced today that Russ Denton has joined the company as Senior Vice President, General Counsel and Secretary, and will lead Caris’ legal and corporate governance efforts.
Prior to joining Caris, Mr. Denton was a partner at Shearman & Sterling LLP, representing clients in mergers and acquisitions and equity financing transactions, including working with Caris as outside counsel in connection with Caris’ growth equity financing transactions. Before his time at Shearman & Sterling, Mr. Denton was a partner at Andrews Kurth Kenyon LLP and an associate at Skadden, Arps, Slate, Meagher and Flom LLP.
“Caris is leading a revolution in healthcare with novel approaches to categorize, visualize and target disease in ways never before possible,” said David D. Halbert, Chairman and CEO of Caris Life Sciences. “We are very pleased to welcome Russ to the Caris team, as his strong guidance and counsel has served us well, and will be invaluable as we continue to advance our mission.”
“I am thrilled to join Caris and work for a company on the cutting edge of healthcare,” said Denton. “I look forward to continuing to help support Caris and its mission.”
Mr. Denton received his J.D. from Stanford Law School, and earned his B.S., magna cum laude, from Duke University.
